Theriva Biologics, Inc. (TOVX)
0.3645
+0.12
(+49.69%)
USD |
NYAM |
Jun 11, 11:14
Theriva Biologics Max Drawdown (5Y) : 99.94% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 99.94% |
| April 30, 2026 | 99.94% |
| March 31, 2026 | 99.94% |
| February 28, 2026 | 99.94% |
| January 31, 2026 | 99.94% |
| December 31, 2025 | 99.94% |
| November 30, 2025 | 99.93% |
| October 31, 2025 | 99.90% |
| September 30, 2025 | 99.87% |
| August 31, 2025 | 99.87% |
| July 31, 2025 | 99.85% |
| June 30, 2025 | 99.85% |
| May 31, 2025 | 99.85% |
| April 30, 2025 | 99.64% |
| March 31, 2025 | 99.62% |
| February 28, 2025 | 99.61% |
| January 31, 2025 | 99.61% |
| December 31, 2024 | 99.61% |
| November 30, 2024 | 99.58% |
| October 31, 2024 | 99.58% |
| September 30, 2024 | 99.53% |
| August 31, 2024 | 98.89% |
| July 31, 2024 | 98.75% |
| June 30, 2024 | 98.75% |
| May 31, 2024 | 98.75% |
| Date | Value |
|---|---|
| April 30, 2024 | 98.75% |
| March 31, 2024 | 98.75% |
| February 29, 2024 | 99.92% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.93% |
| November 30, 2023 | 99.94% |
| October 31, 2023 | 99.94% |
| September 30, 2023 | 99.94% |
| August 31, 2023 | 99.94% |
| July 31, 2023 | 99.94% |
| June 30, 2023 | 99.94% |
| May 31, 2023 | 99.94% |
| April 30, 2023 | 99.94% |
| March 31, 2023 | 99.94% |
| February 28, 2023 | 99.94% |
| January 31, 2023 | 99.94% |
| December 31, 2022 | 99.94% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.94% |
| September 30, 2022 | 99.94% |
| August 31, 2022 | 99.94% |
| July 31, 2022 | 99.94% |
| June 30, 2022 | 99.94% |
| May 31, 2022 | 99.94% |
| April 30, 2022 | 99.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 42.46% |
| Savara, Inc. | 97.41% |
| Vericel Corp. | 73.97% |
| Biogen, Inc. | 72.66% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -85.94 |
| Beta (5Y) | 1.103 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.74% |
| Historical Sharpe Ratio (5Y) | -0.827 |
| Historical Sortino (5Y) | -1.457 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.41% |